Lumonus Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 62

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $19.8M

  • Investors
  • 4

Lumonus General Information

Description

Developer of a user-centric software designed to empower oncology care teams through AI-powered workflows. The company offers intelligent automation for physicians, treatment planning reimagined, and a learning health system, enabling healthcare providers to enhance efficiency, quality, and patient care.

Contact Information

Website
www.lumonus.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 702/100 Walker Street North
  • Sydney, New South Wales 2060
  • Australia
+61 0410
Primary Industry
Enterprise Systems (Healthcare)
Other Industries
Other Healthcare Technology Systems
Vertical(s)
SaaS, Artificial Intelligence & Machine Learning, Life Sciences, Oncology, Mobile
Corporate Office
  • 702/100 Walker Street North
  • Sydney, New South Wales 2060
  • Australia
+61 0410

Lumonus Timeline

202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Lumonus Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series B) 04-Mar-2026 $19.8M Completed Generating Revenue
1. Early Stage VC 25-Mar-2025 Completed Generating Revenue
To view Lumonus’s complete valuation and funding history, request access »

Lumonus Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B
Series A2
To view Lumonus’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Lumonus Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Lumonus Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Aviron Investments Asset Manager Minority
Brandon Capital Venture Capital Minority
Investible Venture Capital Minority
Oncology Ventures Venture Capital Minority
To view Lumonus’s complete investors history, request access »

Ready to get started?

Request a free trial

Lumonus FAQs

  • When was Lumonus founded?

    Lumonus was founded in 2023.

  • Where is Lumonus headquartered?

    Lumonus is headquartered in Sydney, Australia.

  • What is the size of Lumonus?

    Lumonus has 62 total employees.

  • What industry is Lumonus in?

    Lumonus’s primary industry is Enterprise Systems (Healthcare).

  • Is Lumonus a private or public company?

    Lumonus is a Private company.

  • What is the current valuation of Lumonus?

    The current valuation of Lumonus is .

  • What is Lumonus’s current revenue?

    The current revenue for Lumonus is .

  • How much funding has Lumonus raised over time?

    Lumonus has raised $20.3M.

  • Who are Lumonus’s investors?

    Aviron Investments, Brandon Capital, Investible, and Oncology Ventures have invested in Lumonus.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process